CN108339044A - 治疗宫颈糜烂的药物组合物及其制备方法 - Google Patents
治疗宫颈糜烂的药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN108339044A CN108339044A CN201810496682.8A CN201810496682A CN108339044A CN 108339044 A CN108339044 A CN 108339044A CN 201810496682 A CN201810496682 A CN 201810496682A CN 108339044 A CN108339044 A CN 108339044A
- Authority
- CN
- China
- Prior art keywords
- parts
- borneol
- cervical erosion
- peppermint
- seng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003628 erosive effect Effects 0.000 title claims abstract description 47
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 41
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 40
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 40
- 229940116229 borneol Drugs 0.000 claims abstract description 40
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 40
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 35
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 35
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 35
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 35
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 35
- 240000002234 Allium sativum Species 0.000 claims abstract description 33
- 235000013500 Melia azadirachta Nutrition 0.000 claims abstract description 33
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 33
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 33
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 33
- 235000004611 garlic Nutrition 0.000 claims abstract description 33
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 32
- 244000237986 Melia azadirachta Species 0.000 claims abstract description 11
- 239000000284 extract Substances 0.000 claims description 68
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 51
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 31
- 241000218176 Corydalis Species 0.000 claims description 30
- 235000016811 Biondella Nutrition 0.000 claims description 28
- 241001530209 Swertia Species 0.000 claims description 28
- 244000097577 Rhus javanica Species 0.000 claims description 27
- 235000010889 Rhus javanica Nutrition 0.000 claims description 27
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 9
- 235000019640 taste Nutrition 0.000 claims description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 8
- 239000000829 suppository Substances 0.000 claims description 8
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 7
- -1 glyceryl laurate ester Chemical class 0.000 claims description 7
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000007938 effervescent tablet Substances 0.000 claims description 5
- 229940074046 glyceryl laurate Drugs 0.000 claims description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 4
- 238000001802 infusion Methods 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 240000001398 Typha domingensis Species 0.000 claims 6
- 241000594394 Hedyotis Species 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 41
- 229940079593 drug Drugs 0.000 abstract description 30
- 208000002193 Pain Diseases 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 15
- 230000001737 promoting effect Effects 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 208000032843 Hemorrhage Diseases 0.000 abstract description 9
- 241000721047 Danaus plexippus Species 0.000 abstract description 8
- 208000003251 Pruritus Diseases 0.000 abstract description 8
- 230000000740 bleeding effect Effects 0.000 abstract description 8
- 208000001848 dysentery Diseases 0.000 abstract description 8
- 230000008961 swelling Effects 0.000 abstract description 8
- 201000004624 Dermatitis Diseases 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 6
- 208000010668 atopic eczema Diseases 0.000 abstract description 6
- 230000004054 inflammatory process Effects 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 6
- 208000008350 Pruritus Vulvae Diseases 0.000 abstract description 5
- 206010056530 Vulvovaginal pruritus Diseases 0.000 abstract description 5
- 230000004087 circulation Effects 0.000 abstract description 5
- 210000003905 vulva Anatomy 0.000 abstract description 5
- 230000003260 anti-sepsis Effects 0.000 abstract description 4
- 208000035861 hematochezia Diseases 0.000 abstract description 4
- 230000001954 sterilising effect Effects 0.000 abstract description 4
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 3
- 238000002560 therapeutic procedure Methods 0.000 abstract description 3
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 238000010792 warming Methods 0.000 abstract description 3
- 230000000295 complement effect Effects 0.000 abstract description 2
- 235000019441 ethanol Nutrition 0.000 description 44
- 241000233948 Typha Species 0.000 description 26
- 240000005343 Azadirachta indica Species 0.000 description 23
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 239000004480 active ingredient Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 241000205585 Aquilegia canadensis Species 0.000 description 6
- 240000005636 Dryobalanops aromatica Species 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 5
- 241001313857 Bletilla striata Species 0.000 description 5
- 244000234609 Portulaca oleracea Species 0.000 description 5
- 235000001855 Portulaca oleracea Nutrition 0.000 description 5
- 241000219784 Sophora Species 0.000 description 5
- 210000000981 epithelium Anatomy 0.000 description 5
- 230000001151 other effect Effects 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 241001672694 Citrus reticulata Species 0.000 description 4
- 241000218158 Clematis Species 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010014080 Ecchymosis Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 201000005702 Pertussis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 201000005630 leukorrhea Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DTGKSKDOIYIVQL-QXFUBDJGSA-N (-)-borneol Chemical compound C1C[C@]2(C)[C@H](O)C[C@H]1C2(C)C DTGKSKDOIYIVQL-QXFUBDJGSA-N 0.000 description 1
- 229930006703 (-)-borneol Natural products 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 240000008027 Akebia quinata Species 0.000 description 1
- 235000007756 Akebia quinata Nutrition 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001986 Amoebic dysentery Diseases 0.000 description 1
- 206010002153 Anal fissure Diseases 0.000 description 1
- 206010059313 Anogenital warts Diseases 0.000 description 1
- 208000016583 Anus disease Diseases 0.000 description 1
- 235000010894 Artemisia argyi Nutrition 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 240000000572 Blumea balsamifera Species 0.000 description 1
- 241000158621 Brucea Species 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010008528 Chillblains Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000907904 Dipterocarpus Species 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000009531 Fissure in Ano Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 241001293752 Gentiana manshurica Species 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241001062009 Indigofera Species 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 241000334160 Isatis Species 0.000 description 1
- 241000207984 Justicia Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 241001518821 Typha orientalis Species 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 229940100688 oral solution Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 125000005314 unsaturated fatty acid group Chemical group 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及医药领域,具体而言,涉及一种治疗宫颈糜烂的药物组合物及其制备方法。药物原料主要包括:苦参,冰片,苦楝果,薄荷,桃树叶,艾叶,白花蛇舌草,大蒜汁等。苦参和冰片作为上述药物组合物的君药,通过热痢、便血、缓解阴肿阴痒、收敛疮疡肿痛主治疗宫颈糜烂。苦楝果和薄荷作为上述药物组合物的臣药,行气止痛、可治瘙痒、防腐杀菌,辅助君药治疗宫颈糜烂,并且缓解瘙痒、疼痛治疗兼症。桃树叶和艾叶作为上述药物组合物的佐药,配合君臣药,治疗温经止血、祛风清热去湿疹的兼证。白花蛇舌草和大蒜汁作为使药,消炎解毒,行气消积治疗炎症,调和其他药物,增加诸药物的疗效。通过多味药的相辅相成达到治疗宫颈糜烂的效果。
Description
技术领域
本发明涉及医药领域,具体而言,涉及一种治疗宫颈糜烂的药物组合物及其制备方法。
背景技术
宫颈糜烂是已婚妇女的常见病和多发病,发病率约占妇科门诊的 60%左右。提高宫颈糜烂的治愈率,对防止宫颈癌的发生有重要意义。
目前治疗宫颈糜烂有多种方法,其中物理治疗是目前应用很广泛的一种治疗方法。宫颈糜烂的主要病理是宫颈局部正常的鳞状上皮脱落,被柱状上皮覆盖。治疗宫颈糜烂的主要机理(方法)是祛除柱状上皮,只要柱状上皮被祛除,正常的鳞状上皮就会重新覆盖宫颈,这就是宫颈糜烂的愈合。
发明内容
本发明的目的在于提供一种治疗宫颈糜烂的药物组合物,该药物组合物对宫颈糜烂的治疗效果较好。
本发明的另一目的在于提供一种治疗宫颈糜烂的药物组合物的制备方法,该方法能够将各原料的有效成分提出,使人体更好地吸收药物的有效成分,使各有效成分能够更好地发挥协同作用,从而使药物达到更好的治疗效果。
本发明解决其技术问题是采用以下技术方案来实现的。
一种治疗宫颈糜烂的药物组合物,治疗宫颈糜烂的药物组合物主要由按重量份数计的以下原料制成:
苦参11-20份,冰片12-19份,苦楝果6-15份,薄荷5-14份,桃树叶3-9份,艾叶2-8份,白花蛇舌草1-7份,大蒜汁1-7份,鸦胆子1-6份,延胡索3-9,青黛3-12份,蒲黄3-9份,薄荷4-12份,龙胆草5-9份。
本发明还提出一种治疗宫颈糜烂的药物组合物的制备方法,包括:
将苦参、苦楝果、薄荷、桃树叶、白花蛇舌草、大蒜汁浸泡8-24 小时,超临界萃取2-4次,将得到的萃取液与冰片混合。
本发明实施例的治疗宫颈糜烂的药物组合物及其制备方法的有益效果是:
本发明实施例提供的治疗宫颈糜烂的药物组合物,苦参和冰片作为上述药物组合物的君药,通过热痢、便血、缓解阴肿阴痒、收敛疮疡肿痛主治疗宫颈糜烂。苦楝果和薄荷作为上述药物组合物的臣药,行气止痛、可治瘙痒、防腐杀菌,辅助君药治疗宫颈糜烂,并且缓解瘙痒、疼痛治疗兼症。桃树叶和艾叶作为上述药物组合物的佐药,配合君臣药,治疗温经止血、祛风清热去湿疹的兼证。白花蛇舌草和大蒜汁作为使药,消炎解毒,行气消积治疗炎症,调和其他药物,增加诸药物的疗效。延胡索、青黛、蒲黄以及龙胆草作为辅助药物,清热解毒、活血止痛、缓解瘙痒,增加君药的药物疗效,达到凉血消斑,泻火定惊等功效。该药物组合物通过多味药的相辅相成达到治疗宫颈糜烂的效果。
将苦参、苦楝果、薄荷、桃树叶、白花蛇舌草、大蒜汁浸泡后进行超临界萃取,萃取物绝无残留的溶剂物质,从而防止了提取过程中引入杂质,萃取过程中不发生化学反应,有效地防止了热敏性物质的氧化和逸散。因此,在萃取物中保持着药用植物的有效成分。可提高各原料的有效利用率。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将对本发明实施例中的技术方案进行清楚、完整地描述。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。
下面对本发明实施例的治疗宫颈糜烂的药物组合物及其制备方法进行具体说明。
一种治疗宫颈糜烂的药物组合物,治疗宫颈糜烂的药物组合物主要由按重量份数计的以下原料制成:
苦参11-20份,冰片12-19份,苦楝果6-15份,薄荷5-14份,桃树叶3-9份,艾叶2-8份,白花蛇舌草1-7份,大蒜汁1-7份,鸦胆子1-6份,延胡索3-9,青黛3-12份,蒲黄3-9份,龙胆草5-9 份。
苦参为豆科植物苦参的干燥根,用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风,外治滴虫性阴道炎。
冰片,又名片脑、桔片、艾片、龙脑香、梅花冰片、羯布罗香、梅花脑、冰片脑、梅冰等,是由菊科艾纳香茎叶或樟科植物龙脑樟枝叶经水蒸汽蒸馏并重结晶而得。亦有用松节油经一系列化学方法工艺而得。其可用于闭证神昏、用于目赤肿痛,喉痹口疮、用于疮疡肿痛,溃后不敛等。
苦参和冰片作为上述药物组合物的君药,通过热痢、便血、缓解阴肿阴痒、收敛疮疡肿痛主治疗宫颈糜烂。
苦楝果,苦楝树的果实,行气止痛;杀虫。主脘腹胁肋疼痛;疝痛;虫积腹痛;头癣;冻疮。
薄荷辛凉性发汗解热药,治流行性感冒、头疼、目赤、身热、咽喉、牙床肿痛等症。外用可治神经痛、皮肤瘙痒、皮疹和湿疹等。平常以薄荷代茶,清心明目。薄荷含有薄荷醇,该物质可清新口气并具有多种药性,可缓解腹痛、胆囊问题如痉挛,还具有防腐杀菌、利尿、化痰、健胃和助消化等功效。
苦楝果和薄荷作为上述药物组合物的臣药,行气止痛、可治瘙痒、防腐杀菌,辅助君药治疗宫颈糜烂,并且缓解瘙痒、疼痛治疗兼症。
桃树叶性平,味苦、辛,归脾经、肾经。有祛风清热,杀虫的功效。主治头风,头痛,风痹,疟疾,湿疹,疮疡,癣疮。
艾叶用于吐血,衄血,崩漏,月经过多,胎漏下血,少腹冷痛,经寒不调,宫冷不孕;外治皮肤瘙痒。醋艾炭温经止血,用于虚寒性出血。
桃树叶和艾叶作为上述药物组合物的佐药,配合君臣药,治疗温经止血、祛风清热去湿疹的兼证。
白花蛇舌草成药味苦、淡,性寒。主要功效是清热解毒、消痛散结、利尿除湿。尤善治疗各种类型炎症。在临床实践中,发现白花蛇舌草若配伍得当,可治疗多种疾病。
大蒜汁解毒杀虫,消肿止痛,止泻止痢,治肺,驱虫,此外还有温脾暖胃。治痈疽肿毒,白秃癣疮,痢疾泄泻,肺痨顿咳,蛔虫蛲虫,饮食积滞,脘腹冷痛,水肿胀满。行气消积,杀虫解毒。用于感冒、菌痢、阿米巴痢疾、肠炎、饮食积滞、痈肿疮疡。
白花蛇舌草和大蒜汁作为使药,消炎解毒,行气消积治疗炎症, 调和其他药物,增加诸药物的疗效。
鸦胆子苦、寒,具有清热解毒、腐蚀赘疣的功效。现代药理研究表明,鸦胆子油的主要成份为不饱和脂肪酸,它们可直接进入癌细胞,破坏质膜系统和线粒体,使肿瘤细胞崩解、死亡。已经广泛应用于临床以治疗恶性肿瘤及尖锐湿疣等异常细胞增生性疾病。
延胡索辛、苦、温。具有活血、行气、止痛等功效。
青黛为爵床酬科植物马蓝、蓼科植物蓼蓝、十字花科植物菘蓝的叶或茎叶经加工制得的干燥粉末、团块或颗粒。青黛性味咸寒,有清热解毒,凉血消斑,泻火定惊等功效。其主要用于温病热盛,斑疹,吐血、咯血,咽痛口疮,小儿惊痫,疮肿,丹毒,蛇虫咬伤等。
蒲黄,中药名。为香蒲科植物水烛香蒲、东方香蒲或同属植物的干燥花粉。蒲黄主治用于吐血,衄血,咯血,崩漏,外伤出血,经闭通经,胸腹刺痛,跌扑肿痛,血淋涩痛。
龙胆草为龙胆科多年生草本植物条叶龙胆等的根和茎,主治清热燥湿;泻肝定惊。湿热黄疸;小便淋痛;阴肿阴痒;湿热带下;肝胆实火之头胀头痛;目赤肿痛;耳聋耳肿;胁痛口苦;热病惊风抽搐。
延胡索、青黛、蒲黄以及龙胆草作为辅助药物,清热解毒、活血止痛、缓解瘙痒,增加君药的药物疗效,达到凉血消斑,泻火定惊等功效。
进一步地,上述原料还可以按照以下重量份进行选取:
苦参12-16份,冰片13-17份,苦楝果8-11份,薄荷9-12份,桃树叶4-7份,艾叶3-6份,白花蛇舌草2-6份,大蒜汁2-5份,鸦胆子3-5份,延胡索4-7,青黛8-11份,蒲黄5-8份,龙胆草6-8 份。
进一步地,上述原料还可以按照以下重量份进行选取:
苦参15份,冰片15份,苦楝果10份,薄荷10份,桃树叶5 份,艾叶5份,白花蛇舌草3份,大蒜汁3份,鸦胆子4份,延胡索 6份,青黛9份,蒲黄6份,龙胆草7份。
进一步地,治疗宫颈糜烂的药物组合物还可以包括按重量份数计的以下组分:
金银花4-10份,小木通3-9份,香樟树2-6份,马齿苋1-5份,白芨4-6份,槐花5-7份。
金银花自古被誉为清热解毒的良药。它性甘寒气芳香,甘寒清热而不伤胃,芳香透达又可祛邪。金银花既能宣散风热,还善清解血毒,用于各种热性病,如身热、发疹、发斑、热毒疮痈、咽喉肿痛等症,均效果显著。
小木通能利尿消肿、通经下乳,治尿路感染、小便不利、肾炎水肿、闭经、乳汁不通。
香樟树的樟树皮解表退热。治高热感冒,麻疹,百日咳,痢疾。
马齿苋全草主治赤白痢疾,赤白带下,肠炎,淋病。
槐花具有改善毛细血管的功能,保持毛细血管正常的抵抗力,增强细胞修复功能。
白芨味苦、甘、涩,性寒,归肺、胃。肝经。有收敛止血,消肿生肌之功,用于内外出血诸证及痈肿、烫伤、手足皲裂、肛裂等。具有较好的收敛止血,消肿生肌功效。随着现代药理学的研究不断深入,发现其对结核杆菌,肿瘤细胞等有明显抑制作用。
金银花和槐花能够增强抵抗力,马齿苋和香樟树能抑制宫颈糜烂进一步发展,小木通能、马齿以及白芨主治赤白、消肿生肌,防止感染,加快宫颈糜烂的愈合速度。
本发明实施例还提供一种上述治疗宫颈糜烂的制备方法,主要包括以下步骤:
将苦参、苦楝果、薄荷、桃树叶、白花蛇舌草、大蒜汁浸泡8-24 小时,超临界萃取2-4次,将得到的萃取液与冰片混合。
超临界萃取全过程不用有机溶剂,因此萃取物绝无残留的溶剂物质,从而防止了提取过程中引入杂质,萃取过程中不发生化学反应,有效地防止了热敏性物质的氧化和逸散。因此,在萃取物中保持着药用植物的有效成分。
进一步地,在本实施例中,还包括:将鸦胆子、延胡索、青黛、蒲黄、龙胆草在70-80℃下采用体积分数为75%-80%的乙醇水溶液醇提1-3小时得到醇提物,将醇提物减压浓缩至无醇味;然后再与萃取液与冰片的混合物混合。
将鸦胆子、延胡索、青黛、蒲黄、龙胆草进行醇提,得到的醇提物总黄酮加入萃取液与冰片的混合物。
进一步地,在醇提步骤之前,还包括:将鸦胆子、延胡索、青黛、蒲黄、龙胆草的混合物微波干燥5-10分钟,然后研磨至粒径小于100 目。
微波干燥不会破坏药物组合物中的有效成分,同时有利于研磨。
在超临界萃取之前浸泡步骤之后,还包括:将浸泡后的苦参、苦楝果、薄荷、桃树叶、白花蛇舌草、大蒜汁的混合物在95-100℃的水中熬煮15-40分钟。
在95-100℃的水中熬煮一端时间,增加有效成分的提取效率和提取速度。增加药效。
在本实施例中,上述制备方法还包括:将萃取液与冰片的混合物加入聚乙二醇、月桂酸甘油酯制成栓剂。
可以理解的是,在本发明的其他实施例中,萃取液与冰片的混合物也可以加入其他辅料制备成栓剂。
此外,在本发明的其他实施例中,也可以将萃取液与冰片的混合物加入柠檬酸、碳酸氢钠制成泡腾片。
本发明实施例中,可以将药物组合物制成常用的剂型,例如颗粒剂、汤剂、粉剂、散剂、酊剂、片剂、胶囊剂、口服液、注射剂等。
以下结合实施例对本发明的特征和性能作进一步的详细描述。
实施例1
本实施例提供一种治疗宫颈糜烂的药物组合物,其主要通过以下步骤制得:
备料:苦参20g,冰片19g,苦楝果15g,薄荷14g,桃树叶9g,艾叶8g,白花蛇舌草7g,大蒜汁7g,鸦胆子6g,延胡索9g,青黛 12g,蒲黄9g,龙胆草9g。
将苦参、苦楝果、薄荷、桃树叶、白花蛇舌草、大蒜汁浸泡15 小时,超临界萃取3次,将得到的萃取液。
将鸦胆子、延胡索、青黛、蒲黄、龙胆草在80℃下采用体积分数为75%的乙醇水溶液醇提1小时得到醇提物,将醇提物减压浓缩至无醇味。
将醇提物、萃取液与冰片混合;加入聚乙二醇、月桂酸甘油酯等辅料制成栓剂。
实施例2
本实施例提供一种治疗宫颈糜烂的药物组合物,其主要通过以下步骤制得:
备料:苦参11g,冰片12g,苦楝果6g,薄荷5g,桃树叶3g,艾叶2g,白花蛇舌草1g,大蒜汁1g,鸦胆子1g,延胡索3g,青黛3g,蒲黄3g,龙胆草5g。
将苦参、苦楝果、薄荷、桃树叶、白花蛇舌草、大蒜汁浸泡24 小时,超临界萃取2次,将得到的萃取液。
将鸦胆子、延胡索、青黛、蒲黄、龙胆草在80℃下采用体积分数为75%的乙醇水溶液醇提3小时得到醇提物,将醇提物减压浓缩至无醇味。
将醇提物、萃取液与冰片混合;加入聚乙二醇、月桂酸甘油酯等辅料制成栓剂。
实施例3
本实施例提供一种治疗宫颈糜烂的药物组合物,其主要通过以下步骤制得:
备料:苦参12g,冰片13g,苦楝果11g,薄荷12g,桃树叶7g,艾叶6g,白花蛇舌草6g,大蒜汁5g,鸦胆子5g,延胡索7g,青黛 11g,蒲黄8g,龙胆草8g。
将苦参、苦楝果、薄荷、桃树叶、白花蛇舌草、大蒜汁浸泡8-24 小时,超临界萃取4次,将得到的萃取液。
将鸦胆子、延胡索、青黛、蒲黄、龙胆草微波干燥10分钟,然后研磨至粒径小于100目,在80℃下采用体积分数为80%的乙醇水溶液醇提3小时得到醇提物,将醇提物减压浓缩至无醇味。
将醇提物、萃取液与冰片混合;加入聚乙二醇、月桂酸甘油酯等辅料制成栓剂。
实施例4
本实施例提供一种治疗宫颈糜烂的药物组合物,其主要通过以下步骤制得:
备料:苦参12g,冰片13g,苦楝果8g,薄荷9g,桃树叶4g,艾叶3g,白花蛇舌草2g,大蒜汁2g,鸦胆子3g,延胡索4g,青黛8g,蒲黄5g,龙胆草6g。
将苦参、苦楝果、薄荷、桃树叶、白花蛇舌草、大蒜汁浸泡8-24 小时,超临界萃取2次,将得到的萃取液。
将鸦胆子、延胡索、青黛、蒲黄、龙胆草微波干燥5分钟,然后研磨至粒径小于100目,在70℃下采用体积分数为80%的乙醇水溶液醇提1小时得到醇提物,将醇提物减压浓缩至无醇味。
将醇提物、萃取液与冰片混合;加入聚乙二醇、月桂酸甘油酯等辅料制成栓剂。
实施例5
本实施例提供一种治疗宫颈糜烂的药物组合物,其主要通过以下步骤制得:
备料:苦参15g,冰片15g,苦楝果10g,薄荷10g,桃树叶5g,艾叶5g,白花蛇舌草3g,大蒜汁3g,鸦胆子4g,延胡索6g,青黛 9g,蒲黄6g,龙胆草7g,金银花10g,小木通9g,香樟树6g,马齿苋5g,白芨6g,槐花7g。
将苦参、苦楝果、薄荷、桃树叶、白花蛇舌草、大蒜汁浸泡8 小时,在100℃的水中熬煮40分钟;超临界萃取3次,将得到的萃取液。
将鸦胆子、延胡索、青黛、蒲黄、龙胆草微波干燥6分钟,然后研磨至粒径小于100目,在70-80℃下采用体积分数为78%的乙醇水溶液醇提2小时得到醇提物,将醇提物减压浓缩至无醇味。
将醇提物、萃取液与冰片混合;加入柠檬酸、碳酸氢钠制成泡腾片。
实施例6
本实施例提供一种治疗宫颈糜烂的药物组合物,其主要通过以下步骤制得:
备料:苦参15g,冰片15g,苦楝果10g,薄荷10g,桃树叶5g,艾叶5g,白花蛇舌草3g,大蒜汁3g,鸦胆子4g,延胡索6g,青黛 9g,蒲黄6g,龙胆草7g,金银花4g,小木通3g,香樟树2g,马齿苋1g,白芨4g,槐花5g。
将苦参、苦楝果、薄荷、桃树叶、白花蛇舌草、大蒜汁浸泡8 小时,在95℃的水中熬煮15分钟;超临界萃取2次,将得到的萃取液。
将鸦胆子、延胡索、青黛、蒲黄、龙胆草微波干燥8分钟,然后研磨至粒径小于100目,在75℃下采用体积分数为75%的乙醇水溶液醇提2小时得到醇提物,将醇提物减压浓缩至无醇味。
将醇提物、萃取液与冰片混合;加入柠檬酸、碳酸氢钠制成泡腾片。
实施例7
本实施例提供一种治疗宫颈糜烂的药物组合物,其主要通过以下步骤制得:
备料:苦参14g,冰片16g,苦楝果10g,薄荷11g,桃树叶6g,艾叶4g,白花蛇舌草3g,大蒜汁4g,鸦胆子4g,延胡索5g,青黛 9g,蒲黄7g,龙胆草6g。
将苦参、苦楝果、薄荷、桃树叶、白花蛇舌草、大蒜汁浸泡8 小时,在95℃的水中熬煮15分钟;超临界萃取2次,将得到的萃取液。
将鸦胆子、延胡索、青黛、蒲黄、龙胆草微波干燥8分钟,然后研磨至粒径小于100目,在75℃下采用体积分数为75%的乙醇水溶液醇提2小时得到醇提物,将醇提物减压浓缩至无醇味。
将醇提物、萃取液与冰片混合;加入柠檬酸、碳酸氢钠制成泡腾片。
试验例1
宫颈糜烂患者53例,符合诊断标准。随机分为治疗组和对照组,治疗组27例,对照组26例。两组患者年龄和病程经统计学处理,差异无显著性意义,具有可比性。
治疗组:取本发明实施例1提供的栓剂,于阴道给药,一次一粒,一日一次,治疗30天。
对照组:市购的妇炎灵,于阴道给药,一次两粒,一日一次,治疗30天。治疗结果如表1所示。
表1 治疗组与对照组疗效对照表
组别 | 数量 | 治愈 | 有效 | 无效 | 总有效率 |
治疗组 | 27 | 20 | 6 | 1 | 96.3% |
对照组 | 26 | 14 | 5 | 7 | 73.1% |
从表1可以看出,本发明实施例1提供的药物组合物的总有效率高达96.3%;高于现有技术中的73.1%。
说明本发明实施1提供的药物组合物能够治疗宫颈糜烂。
试验例2
将实施例1-实施例7制备得到的药物组合物对宫颈糜烂患者进行治疗,发现实施例5与实施例6与实施例7制备得到的药物组合物对宫颈糜烂治愈的平均时间比其他实施例短3-5天。
以上所述仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (10)
1.一种治疗宫颈糜烂的药物组合物,其特征在于,所述治疗宫颈糜烂的药物组合物主要由按重量份数计的以下原料制成:
苦参11-20份,冰片12-19份,苦楝果6-15份,薄荷5-14份,桃树叶3-9份,艾叶2-8份,白花蛇舌草1-7份,大蒜汁1-7份,鸦胆子1-6份,延胡索3-9份,青黛3-12份,蒲黄3-9份,龙胆草5-9份。
2.根据权利要求1所述的治疗宫颈糜烂的药物组合物,其特征在于,主要由按重量份数计的以下原料制成:
所述苦参12-16份,所述冰片13-17份,所述苦楝果8-11份,所述薄荷9-12份,所述桃树叶4-7份,所述艾叶3-6份,所述白花蛇舌草2-6份,所述大蒜汁2-5份,所述鸦胆子3-5份,所述延胡索4-7份,所述青黛8-11份,所述蒲黄5-8份,所述龙胆草6-8份。
3.根据权利要求1所述的治疗宫颈糜烂的药物组合物,其特征在于,主要由按重量份数计的以下原料制成:
所述苦参15份,所述冰片15份,所述苦楝果10份,所述薄荷10份,所述桃树叶5份,所述艾叶5份,所述白花蛇舌草3份,所述大蒜汁3份,所述鸦胆子4份,所述延胡索6份,所述青黛9份,所述蒲黄6份,所述龙胆草7份。
4.根据权利要求1所述的治疗宫颈糜烂的药物组合物,其特征在于,所述原料还包括按重量份数计的以下组分:
所述苦参14份,所述冰片16份,所述苦楝果10份,所述薄荷11份,所述桃树叶6份,所述艾叶4份,所述白花蛇舌草3份,所述大蒜汁4份,所述鸦胆子4份,所述延胡索5份,所述青黛9份,所述蒲黄7份,所述龙胆草6份。
5.一种如权利要求1-4任一项所述的治疗宫颈糜烂的药物组合物的制备方法,其特征在于,包括:
将所述苦参、所述苦楝果、所述薄荷、所述桃树叶、所述白花蛇舌草、所述大蒜汁浸泡8-24小时,超临界萃取2-4次,将得到的萃取液与所述冰片混合。
6.根据权利要求5所述的制备方法,其特征在于,还包括:
将所述鸦胆子、所述延胡索、所述青黛、所述蒲黄、所述龙胆草在70-80℃下采用体积分数为75%-80%的乙醇水溶液醇提1-3小时得到醇提物,将所述醇提物减压浓缩至无醇味;然后再与所述萃取液与所述冰片的混合物混合。
7.根据权利要求6所述的制备方法,其特征在于,在醇提步骤之前,还包括:将所述鸦胆子、所述延胡索、所述青黛、所述蒲黄、所述龙胆草的混合物微波干燥5-10分钟,然后研磨至粒径小于100目。
8.根据权利要求5所述的制备方法,其特征在于,在超临界萃取之前浸泡步骤之后,还包括:将浸泡后的所述苦参、所述苦楝果、所述薄荷、所述桃树叶、所述白花蛇舌草、所述大蒜汁的混合物在95-100℃的水中熬煮15-40分钟。
9.根据权利要求5所述的制备方法,其特征在于,还包括:将所述萃取液与所述冰片的混合物加入聚乙二醇、月桂酸甘油酯制成栓剂。
10.根据权利要求5所述的制备方法,其特征在于,还包括:将所述萃取液与所述冰片的混合物加入柠檬酸、碳酸氢钠制成泡腾片。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810496682.8A CN108339044A (zh) | 2018-05-22 | 2018-05-22 | 治疗宫颈糜烂的药物组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810496682.8A CN108339044A (zh) | 2018-05-22 | 2018-05-22 | 治疗宫颈糜烂的药物组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108339044A true CN108339044A (zh) | 2018-07-31 |
Family
ID=62956417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810496682.8A Pending CN108339044A (zh) | 2018-05-22 | 2018-05-22 | 治疗宫颈糜烂的药物组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108339044A (zh) |
-
2018
- 2018-05-22 CN CN201810496682.8A patent/CN108339044A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091203B (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
CN103041173B (zh) | 一种治疗皮炎、湿疹的中药外用制剂及其制备方法 | |
CN103316146B (zh) | 一种麻醉用中药制剂 | |
CN105362410B (zh) | 一种治疗烧烫伤的中药制剂及制备方法 | |
CN101940703A (zh) | 一种具有治疗和调整保健作用的酊剂 | |
CN106806758A (zh) | 一种治疗痤疮的中药制剂 | |
CN105662996A (zh) | 治疗月经相关性痤疮的中药面膜 | |
CN104274662A (zh) | 痒必治 | |
CN106237247A (zh) | 一种治疗妇科炎症的中药组合物 | |
CN106389881A (zh) | 一种活血散瘀膏 | |
CN103721138B (zh) | 一种治疗酒糟鼻的中药外用制剂及其制备方法 | |
CN108339044A (zh) | 治疗宫颈糜烂的药物组合物及其制备方法 | |
CN102258602B (zh) | 治疗风湿、类风湿的中药组合物及其制备方法 | |
CN104922449A (zh) | 一种中药消毒液及其制备方法 | |
CN104983972A (zh) | 一种治疗麦粒肿的滴剂及其制备方法 | |
CN104721753A (zh) | 一种治疗肝风内动型脑瘤的药物及制备方法 | |
CN104623304A (zh) | 一种治疗湿热毒蕴型慢性皮肤溃疡的洗剂及其制备方法 | |
CN104971286A (zh) | 一种治疗肩腰腿不适症的中药组合物 | |
CN103948709B (zh) | 一种维吾尔药热合美康宫栓剂及其制备方法 | |
CN105853843A (zh) | 一种临床用小儿伤口护理的药物组合物及其制备方法 | |
CN106511772A (zh) | 一种治疗外科感染的药物及其制备方法 | |
CN106692821A (zh) | 一种治疗神经外科术后头痛的中药制剂 | |
CN104815077A (zh) | 一种检验科外伤杀菌消炎物质及其制备方法 | |
CN105770115A (zh) | 一种治疗湿疹的中药药膏 | |
CN105535853A (zh) | 一种临床护理上用于治疗褥疮的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180731 |
|
RJ01 | Rejection of invention patent application after publication |